• 제목/요약/키워드: Pulmonary Hypertension

검색결과 388건 처리시간 0.022초

Association Between Angiotensin II Receptor Blockers and the Risk of Lung Cancer Among Patients With Hypertension From the Korean National Health Insurance Service-National Health Screening Cohort

  • Moon, Sungji;Lee, Hae-Young;Jang, Jieun;Park, Sue K.
    • Journal of Preventive Medicine and Public Health
    • /
    • 제53권6호
    • /
    • pp.476-486
    • /
    • 2020
  • Objectives: The objective of this study was to estimate the risk of lung cancer in relation to angiotensin II receptor blocker (ARB) use among patients with hypertension from the Korean National Health Insurance Service-National Health Screening Cohort. Methods: We conducted a retrospective cohort study of patients with hypertension who started to take antihypertensive medications and had a treatment period of at least 6 months. We calculated the weighted hazard ratios (HRs) and their 95% confidence intervals (CIs) of lung cancer associated with ARB use compared with calcium channel blocker (CCB) use using inverse probability treatment weighting. Results: Among a total of 60 469 subjects with a median follow-up time of 7.8 years, 476 cases of lung cancer were identified. ARB use had a protective effect on lung cancer compared with CCB use (HR, 0.75; 95% CI, 0.59 to 0.96). Consistent findings were found in analyses considering patients who changed or discontinued their medication (HR, 0.50; 95% CI, 0.32 to 0.77), as well as for women (HR, 0.56; 95% CI, 0.34 to 0.93), patients without chronic obstructive pulmonary disease (HR, 0.75; 95% CI, 0.56 to 1.00), never-smokers (HR, 0.64; 95% CI, 0.42 to 0.99), and non-drinkers (HR, 0.69; 95% CI, 0.49 to 0.97). In analyses with different comparison antihypertensive medications, the overall protective effects of ARBs on lung cancer risk remained consistent. Conclusions: The results of the present study suggest that ARBs could decrease the risk of lung cancer. More evidence is needed to establish the causal effect of ARBs on the incidence of lung cancer.

Association between Thioridazine Use and Cancer Risk in Adult Patients with Schizophrenia-A Population-Based Study

  • Chang, Cheng-Chen;Hsieh, Ming-Hong;Wang, Jong-Yi;Chiu, Nan-Ying;Wang, Yu-Hsun;Chiou, Jeng-Yuan;Huang, Hsiang-Hsiung;Ju, Po-Chung
    • Psychiatry investigation
    • /
    • 제15권11호
    • /
    • pp.1064-1070
    • /
    • 2018
  • Objective Several cell line studies have demonstrated thioridazine's anticancer, multidrug resistance-reversing and apoptosis-inducing properties in various tumors. We conducted this nationwide population-based study to investigate the association between thioridazine use and cancer risk among adult patients with schizophrenia. Methods Based on the Psychiatric Inpatient Medical Claim of the National Health Insurance Research Database of Taiwan, a total of 185,689 insured psychiatric patients during 2000 to 2005 were identified. After excluding patients with prior history of schizophrenia, only 42,273 newly diagnosed patients were included. Among them, 1,631 patients ever receiving thioridazine for more than 30 days within 6 months were selected and paired with 6,256 randomly selected non-thioridazine controls. These patients were traced till 2012/12/31 to see if they have any malignancy. Results The incidence rates of hypertension and cerebrovascular disease were higher among cases than among matched controls. The incidence of hyperlipidemia, coronary artery disease and chronic pulmonary disease did not differ between the two groups. By using Cox proportional hazard model for cancer incidence, the crude hazard ratio was significantly higher in age, hypertension, hyperlipidemia, cerebrovascular disease, coronary artery disease and chronic pulmornary disease. However, after adjusting for other covariates, only age and hypertension remained significant. Thioridazine use in adult patients with schizophrenia had no significant association with cancer. Conclusion Despite our finding that thioridazine use had no prevention in cancer in adult patients with schizophrenia. Based on the biological activity, thioridazine is a potential anticancer drug and further investigation in human with cancer is warranted.

폐동맥 침범을 첫 임상소견으로 발현한 타카야수동맥염 1예 (A Case of Pulmonary Artery Involvement as the First Manifestation of Takayasu's Arteritis)

  • 송준창;이상학;송소향;이숙영;김석찬;김영균;김관형;문화식;송정섭;박성학;김기태;송경섭
    • Tuberculosis and Respiratory Diseases
    • /
    • 제56권6호
    • /
    • pp.677-682
    • /
    • 2004
  • 저자들은 타카야수동맥염에 전형적인 맥박 감소, 사지 혈압의 차이, 사지 파행 등의 증상 없이 기침, 흉통, 객혈과 체중 감소의 호흡기 증상과 전신증상을 주소로 내원한 17세 남자 환자에서 진찰소견과 폐혈관조영술을 통해 폐동맥염을 확인하고, 대동맥조영술을 통해 쇄골하동맥과 온목동맥의 협착을 관찰하여 타카야수동맥염으로 진단한 증례를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

심장외폰탄수술의 조기성적 (Early Results of Extracardiac Fontan Operation)

  • 김웅한;정도현;김수철;전홍주;이창하;김욱성;오삼세;정철현;나찬영
    • Journal of Chest Surgery
    • /
    • 제31권7호
    • /
    • pp.650-659
    • /
    • 1998
  • 부천세종병원에서는 '96년 8월부터 '97년 8월까지 22명의 환자에게 심장외폰탄 (extracardiac Fontan) 수술을 시행하였다. 남자 14명, 여자 8명이었으며, 진단별로는 단심실증 16명(우심실형 12명, 좌심실형 4명), 삼첨판폐쇄증 4명, 좌측이소성(left isomerism), 대혈관전위증, 심실중격결손증이 있으면서 폐동맥협착증이 있는 환자 1명, 그리고 Criss-Cross 심장이면서 비대칭심실이 있는 1명이었다. 연령은 22개월부터 26세까지 분포하였고 폐동맥압은 평균 11.7$\pm$3.1 mmHg이었다. 선행수술로 양방향성대정맥폐동맥단락술(bidirectional cavopulmonary shunt)을 시행한 환자가 15명으로 평균 15.6$\pm$3.4개월의 기간을 두고 수술을 시행하였고, 고전적 글렌 수술 후 14년만에 Fontan 수술을 시행한 환자가 1명 있었다. 전대정맥폐동맥단락술(total cavopulmonary shunt, Kawashima operation)후 폐동-정맥루(pulmonary arteriovenous fistula) 발생으로 평균 37.5$\pm$20개월만에 수술을 받은 환자가 4명 있었고, 2명의 환자는 선행수술 없이 심장외폰탄수술을 시행하였다.

  • PDF

폐쇄성 수면 무호흡증후군 환자에서 혈압 및 폐기능의 변화에 관한 연구 (The Changes of Pulmonary Function and Systemic Blood Pressure in Patients with Obstructive Sleep Apnea Syndrome)

  • 문화식;이숙영;최영미;김치홍;권순석;김영균;김관형;송정섭;박성학
    • Tuberculosis and Respiratory Diseases
    • /
    • 제42권2호
    • /
    • pp.206-217
    • /
    • 1995
  • 연구배경: 폐쇄성 수면 무호흡증후군 환자들은 기도저항을 증가시킬 수 있는 상기도의 해부학적 혹은 기능적 특성을 가지고 있을 뿐만 아니라 이들에게 흔히 동반되는 비만과 같은 체형상의 특성은 다른 폐기능의 변화도 가져올 수 있고, 이러한 폐기능의 변화는 수면 무호흡시 나타나는 저산소증 및 환자의 임상양상에 영향을 미칠 수 있을 것으로 생각되었다. 또한 현재까지 병태생리학적 관련성에 대하여 많은 논란이 있으나 수면 무호흡증후군은 많은 환자에서 고혈압을 동반하는것으로 알려져 있다. 따라서 저자들은 폐쇄성 수면 무호흡증후군 환자들에서 기도저항을 포함한 폐기능 검사소견과 수면다원검사 각 지표 상호간의 관련성 여부를 관찰하고, 이들중 고혈압을 동반하고 있는 환자들과 혈압이 정상인 환자들에서 연령, 비만도, 수면다원검사의 각 지표, 폐기능 검사소견 사이에 어떠한 차이점이 있는지 살펴 보고자 하였다. 방법: 수면장애 크리닉에서 수면설문지검사와 수면 다원검사를 실시하여 무호흡지수가 5이상인 폐쇄성 수면 무호흡증후군 환자 32명을 대상으로 하였다. 폐기능 검사는 주간의 각성상태에서 body plethysmograph를 이용하여 기도저항, 일산화탄소 폐확산능, 노력성호기곡선, 기능적 잔기용량과 총폐용량을 포함한 폐의 용적과 용량을 측정하였고, 수축기혈압이 160mmHg 이상이거나 이완기혈압이 95mmHg이상으로 고혈압의 병력이 있어 항고혈압제를 복용중인 12명(37.5%)을 고혈압환자군으로 하였다. 이들에서 연령, 비만도, 무호흡지수, 호흡장애지수, 수면중 동맥혈 최저산소포화도 및 산소탈포화정도, 폐기능 검사소견들 상호간의 관련성을 검증하였으며 고현압환자군과 혈압이 정상인 환자군을 구분하여 비교함으로서 두군간에 어떠한 차이점이 있는지 살펴 보았다. 결과: 1) 비만도는 무호흡지수, 호흡장애지수, 수면중 동맥혈 최저산소포화도 및 산소탈포화정도와 상호관련성이 있었다. 2) 수면중 동맥혈 최저산소포화도는 무호흡지수, 호흡장애지수와 각각 유의한 역상관관계를 나타냈으며 산소탈포화정도는 무호흡지수, 호흡장애지수와 각각 유의한 상관관계가 있었다. 3) 주간에 실시한 폐기능검사중 기도저항과 무호흡지수는 유의한 상관관계가 있었으며, 일산화탄소 확산능은 수면중 산소탈포화정도와 유의한 역상관관계를 보였다. 4) 비만도와 $FEV_1,\;FEV_1/FVC$, DLco 사이에는 각각 역상관관계가 있었다. 5) 고혈압환자군이 혈압이 정상인 환자군에 비하여 평균연령이 높았으나 비만도, 무호흡지수, 호흡장애지수, 동맥혈 최저산소포화도 및 산소탈포화정도, 폐기능 검사소견등에는 유의한 차이가 없었다. 결론: 이상의 결과에서 비만은 폐쇄성 수면 무호흡증후군의 발생과 밀접한 관계가 있으며, 무호흡지수와 호흡장애지수는 수면중 저산소증의 정도를 반영하는 유의한 지표였다. 주간의 각성시 폐기능검사중 기도저항은 무호흡지수와 상관관계가 있었으므로 기도저항의 측정은 폐쇄성 수면 무호흡의 발생 가능성을 예측하는 보조적 방법으로 이용될 수 있으며, 일산화탄소 확산능은 수면중 저산소증의 정도와 관계가 있었으므로 이들 환자의 진단과 치료시 폐기능의 정확한 평가가 필요하다고 생각되었다. 그러나 폐쇄성 수면 무호흡증후군과 고혈압의 병태생리학적 연관성을 이해하기 위해서는 앞으로 관찰방법을 달리한 다각적인 연구가 필요할 것으로 생각되었다.

  • PDF

심실 중격 결손과 동맥관 개존증을 동반한 아이젠멩거 증후군 환자에서의 심장-폐이식 수술 -1예 보고- (Heart-Lung Transplantation in a Patient with VSD, PDA and Eisenmenger′s Syndrome)

  • 홍유선;김도형;함석진;이교준;이두연;권혁문;김형중;조상호;백효채
    • Journal of Chest Surgery
    • /
    • 제36권6호
    • /
    • pp.418-421
    • /
    • 2003
  • 심장-폐이식은 현재 선천성 심장 질환에 의한 이차성 폐동맥 고혈압 환자에서 최종적 치료로 알려져 있다. 본 41세 남자 환자는 동맥관 개존증에 의한 이차성 페동맥 고혈압으로 진단되었으며 심도자 검사 결과 대동맥압 130/80 mean 100 mmHg, 폐동맥 130/80 mean 109 mmHg, 우심실 130/20 mmHg, 우심방 mean 20 mmHg이었고 우측 폐동맥의 직경이 7.5 cm로 심한 확장소견이 있어 심폐이식을 필요로 하였다. 장기 공여자는 24세 남자 환자로 교통사고에 의해 뇌 경막하 출혈로 타 병원에서 뇌사 판정을 받았다. 수술은 심폐 바이페스하에 동맥관 개존증을 결찰하고 심폐이식술을 시행하였다. 수술 후 1일째 호흡기를 이탈하였으며 3일째 일반 병실로 전원되었고 33일째 퇴원하였으며 41일째 시행한 심근과 폐 조직 검사 소견에서 거부 반응은 없었다.

선천성 및 후천성 심질환의 개심술 (A Clinical Evaluatuin on Open Heart Surgery of Congenital and Acquired Heart Disease)

  • 김근호
    • Journal of Chest Surgery
    • /
    • 제12권1호
    • /
    • pp.33-42
    • /
    • 1979
  • The present study reports 41 cases of congenital and acquired heart diseases, who received open heart surgery under extracorporeal circulation [ECC] by Sarns Heart-Lung-Machine [HLM] at the Department of Thoracic and Cardiovascular Surgery, Hanyang University Hospital during the` period between July 1975 and February 1979. The priming of pump oxygenator was carried out by the hemodilution method using Hartman`s solution, whole blood, and fresh human plasma. The rate of hemodilution was in the average of 50.8 ml/kg. ECC was performed at the average perfusion flow rate of 85.0 ml/kg/min [2.43 L./ kg/2] and at moderate hypothermia. In the total cardiopulmonary bypass, arterial pressure ranged between 55 mmHg and 90 mmHg, but generally maintaining over 70 mmHg. Patient age ranged between 2 and 54 year old, in congenital heart diseases, between 2 and 28, in acquired heart diseases, between 17 and 54 Sex ratio of male to female was 20:21. The cases include a case of pulmonary valvular stenosis, 4 cases of atrial septal defect, 9 cases of ventricular septal defect, 9 cases of tetralogy of Fallot, 5 cases of pentalogy of Fallot, 3 cases of atypical multiple anomalies 7 cases of mitral stenosis or insufficiency, a case of myxoma in left atrium, and a case of ruptured aneurysm of Valsalva`s sinus. The surgical managements were 16 valvulotomy for pulmonary valvular stenosis, 2 Teflon patch graft closure and 5 simple suture closure of atrial septal defect, 16 Teflon patch graft closure and 5 simple suture closure of ventricular septal defect, 12 pericardial patch graft for infundibular stenosis of right ventricle, one anastomosis between left superior vena cava and right atrium, 2 open mitral commissurotomy, 5 mitral valve replacement using Starr-Edward`s ball valve, porcine xenograft by Hancock, by Carpentier-Edward, or Angell-Shiley, one removal of left atrial myxoma, and a repair of ruptured aneurysm of Valsalva`s sinus. Four [9.7%] out 41 cases expired postoperatively and the rest of 37 cases survived with satisfactory results. The causes of death were one coronary embolism in tetralogy of Fallot, 2 postoperative lower cardiac output in atypical multiple anomalies, and one right heart failure in large: ventricular septal defect with pulmonary hypertension.

  • PDF

전호(前胡)가 Bleomycin에 의한 폐 섬유화에 미치는 영향 (The Effects of Peucedani Radix on the Bleomycin-Induced Lung Fibrosis)

  • 김현지;이해자;박은정
    • 대한한방소아과학회지
    • /
    • 제22권2호
    • /
    • pp.37-49
    • /
    • 2008
  • Objectives : Idiopathic pulmonary fibrosis (IPF) is chronic fibrotic interstitial pneumonia and the pathogenesis is unknown. Peucedani Radix is well-known for the treatment of respiratory diseases and pulmonary hypertension. This study was to evaluate the effectiveness of Peucedani Radix on the bleomycin-induced lung fibrosis model (BLFM) in mouse. Methods : We induced lung fibrosis by intratracheal instillation of bleomycin in C57BL/6J. We compared two groups BLFM without Peucedani Radix (group I) and BLFM with Peucedani Radix (group II). We performed bronchoalveolar lavages (BAL) and obtained lung specimens from both group I and II on the 7th (A) and 21st (B) day, and also for the normal group. We compared with group I and II to find BAL by using ANOVA test and to find pathologic symptoms by using semiquantitative histological index (SHI). Results : In BAL, total cell counts, lymphocytes, and neutrophils was increased in both group I and II comparing with normal group. However, lymphocyte level was decreased more in group IIB than group IB. It was statistically significant. In microscopic findings, scores of SHI in normal group, group IB and IIB were 0.33, 4.47, and 1.96 each. Conclusions : Peucedani Radix might have inhibitory effect on lung fibrosis by reducing inflammatory cells in bleomycin-induced lung fibrosis model in mouse.

  • PDF

Clinical Observation of Whole Brain Radiotherapy Concomitant with Targeted Therapy for Brain Metastasis in Non-small Cell Lung Cancer Patients with Chemotherapy Failure

  • Cai, Yong;Wang, Ji-Ying;Liu, Hui
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권10호
    • /
    • pp.5699-5703
    • /
    • 2013
  • Objective: To investigate the clinical effects of whole brain radiotherapy concomitant with targeted therapy for brain metastasis in non-small cell lung cancer (NSCLC) patients with chemotherapy failure. Materials and Methods: Of the 157 NSCLC patients with chemotherapy failure followed by brain metastasis admitted in our hospital from January 2009 to August 2012, the combination group (65 cases) were treated with EGFR-TKI combined with whole brain radiotherapy while the radiotherapy group (92 cases) were given whole brain radiotherapy only. Short-term effects were evaluated based on the increased MRI in brain 1 month after whole brain radiotherapy. Intracranial hypertension responses, hematological toxicity reactions and clinical effects of both groups were observed. Results: There were more adverse reactions in the combination group than in radiotherapy group, but no significant differences were observed between the two groups in response rate (RR) and disease control rate (DCR) (P>0.05). Medium progression free survival (PFS), medium overall survival (OS) and 1-year survival rate in combination group were 6.0 months, 10.6 months and 42.3%, while in the radiotherapy group they were 3.4 months, 7.7 months and 28.0%, respectively, which indicated that there were significant differences in PFS and OS between the two groups (P<0.05). Additionally, RPA grading of each factor in the combination group was a risk factor closely related with survival, with medium PFS in EGFR and KRAS mutation patients being 8.2 months and 11.2 months, and OS being 3.6 months and 6.3 months, respectively. Conclusions: Whole brain radiotherapy concomitant with target therapy is favorable for adverse reaction tolerance and clinical effects, being superior in treating brain metastasis in NSCLC patients with chemotherapy failure and thus deserves to be widely applied in the clinic.

신생아및 영아기 활로씨 사징증의 완전 교정술 (Complete Repair of Tetralogy of Fallot in Neonate or Infancy)

  • 이정렬
    • Journal of Chest Surgery
    • /
    • 제25권1호
    • /
    • pp.32-41
    • /
    • 1992
  • From August 1982 to December 1991, 58 consecutive infants with tetralogy of Fallot underwent primary repair. Age ranged from 22 days to twelve months [n=58, 8.7$\pm$2.7 months] and body weight from 3.1 to 13 kilograms [n=58, 7.8$\pm$1.7 kilograms]. Qne infant had absence of the pulmonary valve; one had Ebstein`s anomaly and one had supramitral ring. Thirty-two patients [56%] experienced anoxic spell. Preoperative pulmonary artery indices were measured in 38 cases, ranging 126-552mm2/M2BSA[n=38, 251$\pm$79mm2/M2BSA]. All infants required a right ventricular outflow tract patch; in 41, the patch extended across the pulmonary valve annulus, in 13 of them, monocusps were constructed. All had patch closure of ventricular septal defect. Two infants had REV operation for avoiding injury to the canal branch of the right coronary artery which cross the right ventricular out flow tract. Post repair PRV/LV were measured at operating room in 40 cases, which revealed mean value of 0.49$\pm$0.12 [range: 0.25-0.74]. The hospital mortality was 10.3% [6 patients], and causes of deaths were right heart failure due to sustained right ventricular hypertension[4] and right ventricular outflow tract obstruction, intractablesuraventricular tachyarrhythmia[1], hypoxia[1] due to residual right to left shunt across the atrial septal defect in patient associated with Ebstein`s anomaly. All infants were doing well at follow-up from 1 to 101 months[20.6 months /patient, 1, 072 patient-month] Serial postoperative echocardiograms revealed no residual ventricular septal defects and estimated RVOT gradients between 0 and 40 mmHg except 3 cases [50, 50, 60 mmHg]. There were no late deaths and late ventricular arrhythmias or congestive heart failure. Redo operations were done in 2 cases because of residual right ventricular outflow tract obstruction. This experience with infants with tetralogy of Fallot suggests that, if mortality is tolerable, eletive repair of tetralogy of Fallot could be reasonably undertaken during the first year of life, and even better results could be anticipated along with improvement of methods of myocardial protection and postoperative care.

  • PDF